A Comparison of -IV and -5 Panel Members' Financial Associations with Industry: A Pernicious Problem Persists

1. TsaiACRosenlichtNZJureidiniJNParryPISpielmansGI 2011 Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature. PLoS Med 8 e1000434 doi:10.1371/journal.pmed.1000434

2. CosgroveLBursztajnHJKrimskySAnayaMWalkerJ 2009 Conflicts of interest and disclosure in the American Psychiatric Association's Clinical Practice Guidelines. Psychother Psychosom 78 228 232

3. LacasseJRLeoJ 2010 Ghostwriting at elite academic medical centers in the United States. PLoS Med 7 e1000230 doi:10.1371/journal.pmed.1000230

4. RoehrB 2011 Professor files complaint of scientific misconduct over allegation of ghostwriting. BMJ 343 d4458 doi:10.1136/bmj.d4458

5. HarrisGCareyB 2008, June 8 Researchers fail to reveal full drug pay. New York Times. Available: http://www.nytimes.com/2008/06/08/us/08conflict.html?pagewanted=all. Accessed 11 January 2012

6. HeresSDavisJMainoKJetzingerEKisslingW 2006 Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry 163 185 194

7. PerlisRPerlisCWuYHwangCJosephM 2005 Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 162 1957 1960

8. AngellM 2010 The illusions of psychiatry. New York Rev Books 58 20 22

9. FrancesA 2010 Opening Pandora's box: The 19 worst suggestions for DSM5. Psychiatric Times 27 9

10. World Health Organization 1992 International statistical classification of disease and related health problems, Tenth Revision (ICD-10) Geneva World Health Organization

11. American Psychiatric Association 2007, July 23 APA names DSM-V task force members: leading experts to revise handbook for diagnosing mental disorders [Press release #07-57]. Available: http://www.dsm5.org/Newsroom/Documents/07-57%20APA%20Announces%20DSM%20Task%20Force%20Members.pdf. Accessed 16 November 2011

12. BekelmanJLiYGrossC 2003 Scope and impact of financial conflicts of interest in biomedical research: A systematic review. JAMA 289 454 465

13. StelfoxHChuaGO'RourkeKDetskyA 1998 Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338 101 106

14. KjaergardLAls-NielsenB 2002 Association between competing interests and authors' conclusions: Epidemiological study of randomised clinical trials published in the BMJ. BMJ 325 249

15. KrimskyS 2010 Combating the funding effect in science: What's beyond transparency? Stanford Law Policy Rev XXI 101 123

16. National Research Council 2009 Conflict of interest in medical research, education, and practice [consensus report]. LoBFieldMJ Washington, DC National Academies Press Available: http://www.iom.edu/Reports/2009/Conflict-of-Interest-in-Medical-Research-Education-and-Practice.aspx. Accessed 11 January 2012

17. MathesonA 2008 Corporate science and the husbandry of scientific and medical knowledge by the pharmaceutical industry. Bio Societies 3 355 382

18. CosgroveLBursztajnHJKrimskyS 2009 Developing unbiased diagnostic and treatment guidelines in psychiatry. N Eng J Med 360 2035 2036

19. PileckiBCCleggJWMcKayD 2011 The influence of corporate and political interests on models of illness in the evolution of the DSM. Eur Psychiatry 26 194 200

20. JørgensenAWHildenJGøtzschePC 2006 Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 331 782 785

21. BhandariMBusseJWJackowskiDMontoriVMSchünemannH 2004 Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Can Med Assoc J 170 477 480

22. LesserLIEbbelingCBGooznerMWypijDLudwigDS 2007 Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 4 e5 doi:10.1371/journal.pmed.0040005

23. CainDMLowensteinGMooreDA 2005 The dirt on coming clean: Perverse effects of disclosing conflicts of interest. J Legal Stud 31 1 25

24. CosgroveLKrimskySVijayaraghavanMSchneiderL 2006 Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychother Psychosom 75 154 160

25. LexchinJO'DonovanO 2010 Prohibiting or ‘managing’ conflict of interest?: A review of policies and procedures in three European drug regulation agencies. Soc Sci Med 70 643 647

26. KatzDCaplanALMerzJF 2003 All gifts large and small: Toward an understanding of the ethics of pharmaceutical industry gift-giving. Am J Bioeth 3 39 46

27. MatherC 2005 The pipeline and the porcupine: Alternate metaphors of the physician-industry relationship. Soc Sci Med 60 1323 1334

28. MaussM 1967 The gift: Forms and functions of exchange in archaic societies (I. Cunnison, Trans.) New York W.W. Norton Co 130

29. MendelsonTBMeltzerMCampbellEGCaplanALKirkpatrickJN 2011 Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med 171 577 584 doi:10.1001/archinternmed.2011.96

30. Institute of Medicine 2011 Clinical practice guidelines we can trust: Report brief Washington (DC) National Academies Press Available: http://www.iom.edu/~/media/Files/Report%20Files/2011/Clinical-Practice-Guidelines-We-Can-Trust/Clinical%20Practice%20Guidelines%202011%20Report%20Brief.pdf. Accessed 30 March 2011

31. American Psychiatric Association 2010 DSM-5 Development: Frequently asked questions. Available: http://www.dsm5.org/about/pages/faq.aspx. Accessed 30 September 2011